SLOAN BIOTECH FUNDS
Sloan Biotech Funds is an investment fund specialized in late stage venture investments.
SLOAN BIOTECH FUNDS
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2012-11-08 | Auspex Pharmaceuticals | Sloan Biotech Funds investment in Series D - Auspex Pharmaceuticals | 25 M USD |
| 2010-10-13 | Auspex Pharmaceuticals | Sloan Biotech Funds investment in Series C - Auspex Pharmaceuticals | 12 M USD |
More informations about "Sloan Biotech Funds"
Sloan Biotech Funds Investor Profile: Portfolio & Exits - PitchBook
Jul 12, 2010 Sloan Biotech Funds's latest investment was on 06-Sep-2013 in Auspex Pharmaceuticals, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most accurate financial data in the industry.See details»
Sloan Biotech Funds - Company Profile and News - Bloomberg …
Sloan Biotech Funds operates as a venture capital firm. The Company serves customers in the United States.See details»
Sloan Biotech Funds - Investments, Portfolio & Company Exits
Nov 8, 2012 Sloan Biotech Funds is an investment fund specialized in late stage venture investments.See details»
Best Biotech ETFs to Watch Right Now | The Motley Fool
Sloan Biotech Funds - Crunchbase
Companies like Sloan Biotech Funds include Ingro Finanz AG, Ohio Biotech Group, and Pioneer Investment Cooperation Fund. Rangos Investments . Rangos Investments is an investment firm specialized in early stage venture investments. ... Browse By: Organizations, People, Events .See details»
Sloan Biotech Funds - CB Insights
Sloan Biotech Funds is a venture capital fund based Las Vegas, Nevada. Use the CB Insights Platform to explore Sloan Biotech Funds's full profile. Sloan Biotech Funds Portfolio Investments, Sloan Biotech Funds Funds, Sloan Biotech Funds ExitsSee details»
How Memorial Sloan Kettering Funds Its Cancer Fight
Jul 1, 2024 Other organizations have good hospitals and research efforts, Klein says in an interview, “but none can harness research to patient care the way we can.” ... Among the other biotech companies’ stock still in MSKCC’s portfolio …See details»
7 Best-Performing Biotech ETFs for December 2024 - NerdWallet
6 days ago Biotech and health care exchange-traded funds let you invest in dozens or even hundreds of companies working on groundbreaking treatments, therapies and vaccines. Many, or all, of the products ...See details»
Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17.
May 12, 2021 May 11 (Reuters) - Ginkgo said on Tuesday it was planning to go public through a merger with a blank-check vehicle backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in one of ...See details»
Differentiated dollars - Nature Biotechnology
Mar 17, 2022 A.W.L. is an advisor to the American Cancer Society’s BrightEdge Impact Fund, a venture philanthropic organization, and the National Center for Advancing Translational Sciences, a government ...See details»
Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for over …
Apr 9, 2021 Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 ...See details»
Sloan Biotech Funds - Updates, News, Events, Signals & Triggers
Sloan Biotech Funds is an investment fund specialized in late stage venture investments. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Investment Firm. Sloan Biotech Funds . Connect to CRM . Save .See details»
Biotech firm Ginkgo in talks with Harry Sloan-led SPAC for
Apr 9, 2021 Biotech startup Ginkgo Bioworks is in talks to go public through a merger with a blank-check firm backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal valued at about $20 ...See details»
Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $15
May 11, 2021 Ginkgo Bioworks will go public through a merger with a blank-check company led by former Hollywood executives Harry Sloan and Jeff Sagansky, in a deal that values the biotech company at $15 ...See details»
Eight Innovative, Virginia Life Science Startups to Know
The heart of the BHCR biohealth cluster is Maryland, with its vast network of government research agencies, the strong university system, and a deep network of established, emerging, and startup life science companies across a wide range of fields, including cell and gene therapy, advanced biomanufacturing, phage therapy, medical devices and more traditional biotech and …See details»
Strategic Innovation Fund - Wikipedia
The Strategic Innovation Fund (SIF) is the program of Innovation, Science and Economic Development Canada designed to support the "Canadian innovation ecosystem," [1] which includes providing "funding to innovative sectors" such as "advanced manufacturing, agri-food, clean technology, clean resources, digital industries, and health and biosciences." [2] [3] [4] …See details»
Series C - Auspex Pharmaceuticals - 2010-10-13 - Crunchbase
Oct 13, 2010 Organization Name . Auspex Pharmaceuticals . Announced Date Oct 13, 2010; Funding Type Series C; Funding Stage Late Stage Venture; Money Raised . $12M. Investors. Edit Investors Section. Number of Investors 4. Number of Partner Investors 1. Investor Name . Partners . Thomas, McNerney & Partners . Pratik Shah: Sloan Biotech Funds — Presidio ...See details»
Hugh W. Sloan Jr. - Wikipedia
Hugh W. Sloan Jr. (born November 1, 1940) was treasurer of the Committee to Re-elect the President, Richard M. Nixon's 1972 campaign committee. Previously, he was an aide to White House Chief of Staff H.R. Haldeman.. He resigned from the Committee to Re-elect over ethics concerns related to actions behind the Watergate scandal. Bob Woodward and Carl Bernstein, …See details»
Hugh W. Sloan Jr. - WikiMili, The Best Wikipedia Reader
Sloan was born in Princeton, New Jersey.He attended Hotchkiss and spent his last year of preparatory school at the Aldenham School in Elstree, Hertfordshire, England. [2] He graduated with a B.A. (Honors) from Princeton University in 1963, and then served in the United States Navy until 1965.. In 1965 he worked as a fund raiser for the Republican Congressional Campaign …See details»